a better way see below and faustmanlab.org
Media Coverage
"Stabilizing Diabetes: Old Drug Could Help Millions"
Boston Herald, June 13, 2017
"Mass General scientists gain insight into how a TB vaccine may reverse diabetes"
Fierce Biotech, June 12, 2017
"The Vaccine for Type-1 Diabetes Is Moving Forward"
TIME, June 2015
“Type I diabetes cure? MGH researchers say new drug could be the answer”
Boston Business Journal, June 2015
“BCG and Autoimmunity Working Group Publishes First Book”
Reuters, April 2014
"Drugs: Research may find route to repairing the sick pancreas"
Financial Times, November 14, 2012
“TB Vaccine Promising as New Way to Fight Type 1 Diabetes”
US News & World Report/Health Day, August 8, 2012
“Research shows promise in reversing Type 1 diabetes”
Los Angeles Times, June 25, 2011
“Generic Tuberculosis Medicine Shows Promise for Reversing Type 1 Diabetes”
Bloomberg, June 24, 2011
“Talk of the Nation Science Friday”
NPR Talk of the Nation, August 29, 2008
“Diabetes: Of Mice and Men”
Newsweek, March 14, 2008
“A Controversial Therapy for Diabetes is Verified”
The New York Times, March 24, 2006
"BCG vaccine could restore proper immune response in type 1 diabetes"
Diabetes.co.uk, June 12, 2017
"100-Year-Old Vaccine May Help Reverse Type 1 Diabetes"
CBS Boston, June 2015
“Here’s How Lee Iacocca Wants To Cure Diabetes”
Forbes, June 2015
“Low C-Peptide Levels May Predict Diabetic Complications, Poor Metabolic Control”
Healio, September 2014
“A New Approach to Battling Autoimmune Diseases”
Special edition to the Washington Post, June 2013
“Human study re-ignites debate over controversial diabetes 'cure' ”
Special edition to the Washington Post, June 2013
“Drug Offers Hope in Diabetes Study”
Wall Street Journal, June 25, 2011
“Cure for Type 1 diabetes?”
UPI, June 25, 2011
“Beyond Insulin: Searching for a Cure to Type 1 Diabetes”
UPI, June 25, 2011
“Two experiments suggest new direction for diabetes”
Reuters, August 25, 2008
“Putting Up with Self”
Scientific American, October 13, 2006
“Confirming Hope on Diabetes”
The Wall Street Journal, March 24, 2006
No comments:
Post a Comment